Marta M Lipinski Selected Research

Parkinson Disease 10

1/2020

The PARK10 gene USP24 is a negative regulator of autophagy and ULK1 protein stability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marta M Lipinski Research Topics

Disease

6	Traumatic Brain Injuries (Traumatic Brain Injury) 09/2022 - 12/2013
3	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 08/2010
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 02/2004
2	Neuroinflammatory Diseases 01/2021 - 01/2015
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2018 - 01/2015
2	Wounds and Injuries (Trauma) 01/2016 - 12/2013
1	Parkinson Disease 10 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Necrosis 01/2018
1	Cognitive Dysfunction 11/2016
1	Gaucher Disease (Gaucher's Disease) 10/2015
1	Inflammation (Inflammations) 03/2014
1	Brain Injuries (Brain Injury) 01/2014
1	Brain Ischemia (Cerebral Ischemia) 12/2013
1	Stroke (Strokes) 12/2013
1	Starvation 06/2010
1	Infections 03/2007

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2004
2	acetylleucineIBA 09/2022 - 01/2021
2	Phosphates (Orthophosphate)IBA 01/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2015
2	Green Fluorescent ProteinsIBA 01/2020 - 01/2014
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2020
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 06/2010
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 08/2010 - 06/2010
1	Glycerophospholipids (Phosphoglycerides)IBA 11/2021
1	Deubiquitinating EnzymesIBA 01/2020
1	Ubiquitin-Specific ProteasesIBA 01/2020
1	Ribosomal Protein S6IBA 01/2020
1	bafilomycin A1IBA 01/2020
1	phosphatidylinositol 3-phosphateIBA 01/2020
1	arachidonyltrifluoromethaneIBA 01/2020
1	Beclin-1IBA 01/2020
1	Autophagy-Related Protein-1 HomologIBA 01/2020
1	Red Fluorescent ProteinIBA 01/2020
1	lysophosphatidylethanolamineIBA 01/2020
1	CalciumIBA 01/2020
1	Cathepsin DIBA 01/2020
1	CeramidesIBA 01/2020
1	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2020
1	Cathepsin LIBA 01/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Group IV Phospholipases A2IBA 01/2020
1	Lysosomal-Associated Membrane Protein 2IBA 01/2020
1	TubulinIBA 01/2020
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2020
1	Lysosomal-Associated Membrane Protein 1IBA 01/2020
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	glycerophosphoethanolamineIBA 01/2019
1	Ether (Diethyl Ether)IBA 01/2019
1	Protein Kinases (Protein Kinase)IBA 01/2018
1	Sucrose (Saccharose)IBA 11/2016
1	EnzymesIBA 10/2015
1	Glucosylceramidase (Glucocerebrosidase)IBA 10/2015
1	CaspasesIBA 03/2014
1	UbiquitinIBA 01/2014
1	Neuroprotective AgentsIBA 12/2013
1	geranylgeranylacetone (teprenone)IBA 12/2013
1	Peptides (Polypeptides)IBA 03/2012
1	Amyloid beta-PeptidesIBA 08/2010
1	Small Interfering RNA (siRNA)IBA 06/2010
1	Phospholipases (Phospholipase)IBA 03/2007
1	Listeria monocytogenes hlyA protein (listeriolysin O)IBA 03/2007

Therapy/Procedure

1	Therapeutics 01/2016
1	Oral Administration 12/2013
1	Aftercare (After-Treatment) 12/2013